NON SMALL CELL LUNG CARCINOMA NSCLC
Clinical trials for NON SMALL CELL LUNG CARCINOMA NSCLC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CARCINOMA NSCLC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CARCINOMA NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets hard-to-treat cancers in early trial
Disease control Not yet recruitingThis study tests a drug called Trastuzumab Rezetecan in 15 adults with advanced solid tumors that have the HER2 protein. The goal is to see if the drug can shrink tumors. Participants get the drug by IV every 3 weeks. This is for people whose cancer has worsened after other treat…
Matched conditions: NON SMALL CELL LUNG CARCINOMA NSCLC
Phase: PHASE2 • Sponsor: Haihua Yuan • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
Can leftover immunotherapy boost chemo? new study aims to find out.
Knowledge-focused Not yet recruitingThis study will check if the amount of pembrolizumab still in the blood when starting chemotherapy affects how well the chemo works. It includes 110 adults with non-small cell lung cancer or head and neck cancer that got worse after immunotherapy. The goal is to understand why so…
Matched conditions: NON SMALL CELL LUNG CARCINOMA NSCLC
Phase: PHASE4 • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC